Pfizer-Abbott lung cancer Rx/Dx delivers on personalised medicine promise
This article was originally published in Clinica
Executive Summary
For the second time in recent weeks, the US FDA has cleared a cancer therapy along with a companion diagnostic, aimed at ensuring a targeted drug has the best chance of working in the intended population.